NLS Pharmaceutics is a NASDAQ listed Swiss-based company engaged in discovery and development of drug therapies for rare and complex central nervous systems disorders.
Lead product candidate, Quilience® is under clinical development to treat excessive daytime sleepiness and cataplexy in narcolepsy.

Location

Alter Postplatz 2, 6370 Stans, Switzerland

Facts & figures
  • Type of organization

    Public company

  • Year of foundation

    2015

  • Number of employees in Switzerland

    1-9

Key business